V. K. Viswanathan

发表

Phylogenomic analysis of Clostridioides difficile ribotype 106 strains reveals novel genetic islands and emergent phenotypes

S. Elliott, G. Vedantam, B. Roxas, 2020, Scientific reports.

Cytokeratin 18 interacts with the enteropathogenic Escherichia coli secreted protein F (EspF) and is redistributed after infection

V. Viswanathan, G. Hecht, A. Koutsouris, 2004, Cellular microbiology.

Enteropathogenic Escherichia coli-Induced Epidermal Growth Factor Receptor Activation Contributes to Physiological Alterations in Intestinal Epithelial Cells

A. Koutsouris, J. L. Roxas, V. K. Viswanathan, 2007, Infection and Immunity.

The Enteropathogenic Escherichia coli-Secreted Protein EspZ Inhibits Host Cell Apoptosis

V. Viswanathan, G. Vedantam, J. S. Wilbur, 2012, Infection and Immunity.

The Alternative Sigma Factor SigL Influences Clostridioides difficile Toxin Production, Sporulation, and Cell Surface Properties

A. E. Clark, G. Vedantam, Katelyn E. Carothers, 2022, Frontiers in Microbiology.

Phylogenomic analysis of Clostridioides difficile ribotype 106 strains reveals novel genetic islands and emergent phenotypes

V. Viswanathan, V. Viswanathan, G. Vedantam, 2020, Scientific Reports.

Modulation of Intestinal Paracellular Transport by Bacterial Pathogens.

J. L. Roxas, V. K. Viswanathan, Virinchipuram Viswanathan, 2018, Comprehensive Physiology.

A Clostridium difficile Cell Wall Glycopolymer Locus Influences Bacterial Shape, Polysaccharide Production and Virulence

M. Mallozzi, G. Vedantam, M. Monteiro, 2016, PLoS pathogens.

Human Hypervirulent Clostridium difficile Strains Exhibit Increased Sporulation as Well as Robust Toxin Production

D. Gerding, Stuart Johnson, V. Viswanathan, 2010, Journal of bacteriology.

Enterohemorrhagic Escherichia coli suppresses inflammatory response to cytokines and its own toxin.

G. Hecht, A. Koutsouris, V. K. Viswanathan, 2009, American journal of physiology. Gastrointestinal and liver physiology.

Enteropathogenic Escherichia coli EspG disrupts microtubules and in conjunction with Orf3 enhances perturbation of the tight junction barrier

J. Kaper, V. Viswanathan, G. Hecht, 2005, Molecular microbiology.

Enteropathogenic Escherichia coli dynamically regulates EGFR signaling in intestinal epithelial cells.

G. Vedantam, J. L. Roxas, V. K. Viswanathan, 2014, American journal of physiology. Gastrointestinal and liver physiology.

Balance of bacterial pro- and anti-inflammatory mediators dictates net effect of enteropathogenic Escherichia coli on intestinal epithelial cells.

Rachna Sharma, G. Hecht, V. K. Viswanathan, 2006, American journal of physiology. Gastrointestinal and liver physiology.

Human Hypervirulent Clostridium difﬁcile Strains Exhibit Increased Sporulation as Well as Robust Toxin Production (cid:1)

D. Gerding, Stuart Johnson, M. Mallozzi, 2010 .

Enteropathogenic E. coli non‐LEE encoded effectors NleH1 and NleH2 attenuate NF‐κB activation

J. Turner, V. Viswanathan, K. Rhee, 2010, Molecular microbiology.

Enteropathogenic Escherichia coli EspH-Mediated Rho GTPase Inhibition Results in Desmosomal Perturbations

J. Kaper, V. Viswanathan, G. Vedantam, 2018, Cellular and molecular gastroenterology and hepatology.

Differing roles of protein kinase C-zeta in disruption of tight junction barrier by enteropathogenic and enterohemorrhagic Escherichia coli.

S. Savkovic, J. Turner, G. Hecht, 2004, Gastroenterology.

The Secreted Effector Protein EspZ Is Essential for Virulence of Rabbit Enteropathogenic Escherichia coli

E. Boedeker, V. Viswanathan, G. Vedantam, 2015, Infection and Immunity.

The Alternative Sigma Factor SigL Influences Clostridioides difficile Toxin Production, Sporulation, and Cell Surface Properties

V. Viswanathan, G. Vedantam, Katelyn E. Carothers, 2022, bioRxiv.

An Engineered Synthetic Biologic Protects Against Clostridium difficile Infection

M. Mallozzi, G. Vedantam, Rebecca McQuade, 2018, Front. Microbiol..

Clostridium difficile infection

V. Viswanathan, M. Mallozzi, G. Vedantam, 2012, Gut microbes.

Surface-Layer Protein A (SlpA) Is a Major Contributor to Host-Cell Adherence of Clostridium difficile

D. Gerding, V. Viswanathan, M. Mallozzi, 2013, PloS one.

Microbes and their products--physiological effects upon mammalian mucosa.

Rachna Sharma, G. Hecht, V. K. Viswanathan, 2004, Advanced drug delivery reviews.

Nonsteroidal Anti-inflammatory Drugs Alter the Microbiota and Exacerbate Clostridium difficile Colitis while Dysregulating the Inflammatory Response

Eric P. Skaar, M. Washington, D. Aronoff, 2018, mBio.

Performance and emission characteristics analysis of Elaeocarpus Ganitrus biodiesel blend using CI engine

V. K. Viswanathan, Pushparaj Thomai, 2021 .

Enteropathogenic E. coli-induced barrier function alteration is not a consequence of host cell apoptosis.

G. Hecht, A. Koutsouris, Andrew W. Weflen, 2008, American journal of physiology. Gastrointestinal and liver physiology.

Comparative Analysis of EspF from Enteropathogenic and Enterohemorrhagic Escherichia coli in Alteration of Epithelial Barrier Function

M. Pilkinton, G. Hecht, A. Koutsouris, 2004, Infection and Immunity.

Clostridium difficile clinical isolates exhibit variable susceptibility and proteome alterations upon exposure to mammalian cationic antimicrobial peptides.

V. Viswanathan, G. Vedantam, Rebecca McQuade, 2012, Anaerobe.

Investigation on Performance and Emission Characteristics of CI Engine Fuelled with Cucurbita Pepo L. and Prosopis Juliflora Seed Oil Biodiesel Blends

V. K. Viswanathan, Pushparaj Thomai, 2020 .

Hybrid optimization and modelling of CI engine performance and emission characteristics of novel hybrid biodiesel blends

Z. Said, A. Afzal, Ü. Ağbulut, 2022, Renewable Energy.